---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-009146"
form_type: "8-K"
ticker: null
cik: "0001292519"
company_name: "INVIVO THERAPEUTICS HOLDINGS CORP."
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T10:43:02.768491+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# InVivo Therapeutics files Chapter 11 bankruptcy, seeks asset sale

## Summary
- Filed voluntary Chapter 11 petitions on Feb 1, 2024 in Delaware Bankruptcy Court.
- Will operate as debtor-in-possession; filed motions for continued business practices and potential asset sale.
- Case administered under 'In re InVivo Therapeutics Holdings Corp., et al.'; claims agent is Kurtzman Carson Consultants.

## SEC filing metadata
- accession: 0001104659-24-009146
- form_type: 8-K
- cik: 0001292519
- company_name: INVIVO THERAPEUTICS HOLDINGS CORP.
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1292519/000110465924009146/0001104659-24-009146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1292519/000110465924009146/tm244807d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-009146
- JSON: https://secwatch.observer/filing/0001104659-24-009146.json
- Plain text: https://secwatch.observer/filing/0001104659-24-009146.txt

## Key facts
- Distress & Bankruptcy
  INVIVO THERAPEUTICS HOLDINGS CORP. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2024-02-01).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2024-02-01
  source text: On February 1, 2024, after considering all strategic alternatives, InVivo Therapeutics Holdings Corp. and its subsidiary InVivo Therapeutics Corporation (together, the “Company”) filed voluntary petitions (the “Voluntary Petitions”) for relief under the provisions of Chapter 11 of Title 11 of the United States Code (the “Code”) in the United States Bankruptcy Court for the District of Delaware (the “Court”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1292519/000110465924009146/0001104659-24-009146-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.